BWA
61
2
F
62
2
NAVI
40
2
DVN
46
-4
UA
29
3
GME
63
-2
EQIX
53
4
WMB
51
3
MCO
61
5
SE
43
2
FFIV
55
5
WYNN
36
2
PNR
66
3
APD
44
9
DE
46
3
CINF
60
3
MNST
47
-3
MAC
68
3
ECL
54
2
RRC
52
-13
BWA
61
2
F
62
2
NAVI
40
2
DVN
46
-4
UA
29
3
GME
63
-2
EQIX
53
4
WMB
51
3
MCO
61
5
SE
43
2
FFIV
55
5
WYNN
36
2
PNR
66
3
APD
44
9
DE
46
3
CINF
60
3
MNST
47
-3
MAC
68
3
ECL
54
2
RRC
52
-13
Financhill
Back

UiPath, Inc. Vs. Nektar Therapeutics Industry Stock Comparison

Sell
46

PATH
UiPath, Inc.

Last Price:
$17.49
Seasonality Move:
-14.79%
Sell
33

NKTR
Nektar Therapeutics

Last Price:
$53.75
Seasonality Move:
11.58%
Sell
46
UiPath, Inc. (PATH) is a Sell

Is UiPath, Inc. a Buy, Sell or Hold?

  • The current UiPath, Inc. [PATH] share price is $18.03. The Score for PATH is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • PATH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $51.12. The Score for NKTR is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PATH Stock Price Chart

What is UiPath, Inc.'s stock price today?

  • The UiPath, Inc. share price today is $18.03
    The current trend is moderately bullish and PATH is experiencing selling pressure, which indicates risk of future bearish movement.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $51.12
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing selling pressure, which indicates risk of future bearish movement.

PATH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.1 Buy
Relative Strength Index (14 RSI): 65.9 Buy
Chaikin Money Flow: -17680211 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.92 - 17.14) Buy
Bollinger Bands (100): (11.14 - 15.8) Buy

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.55 Sell
Relative Strength Index (14 RSI): 39.75 Sell
Chaikin Money Flow: -893008 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.73 - 61.07) Sell
Bollinger Bands (100): (32.3 - 62.42) Buy

PATH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.66 Buy
20-day SMA: 15.22 Buy
50-day SMA: 15.38 Buy
200-day SMA: 12.71 Buy
8-day EMA: 17.61 Buy
20-day EMA: 16.17 Buy
50-day EMA: 15.07 Buy
200-day EMA: 13.6 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.44 Sell
20-day SMA: 58.08 Sell
50-day SMA: 58.52 Sell
200-day SMA: 30.43 Buy
8-day EMA: 56.58 Sell
20-day EMA: 57.71 Sell
50-day EMA: 55.82 Sell
200-day EMA: 37.69 Buy

UiPath, Inc. Earnings Growth & PATH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.04 per share, an increase next quarter of $0.10 per share, a decrease this year of $0.01 per share, and an increase next year of $0.20 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

UiPath, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):